Get Started

TPST

NASD Tempest Therapeutics, Inc.
Nov 6, 2026 · 2:14 AM ET EOD Market Closed

$0.3752 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3752, $0.1047 below the day’s high of $0.4799

YTD change
-86.93%
vs 20-day SMA
-35.20%
vs 200-day SMA
-74.50%

Price ranges

Previous day
$0.4552 $0.4997
open $0.4620 close $0.4633
+$0.0013 (+0.28%)
Today
$0.3706 $0.4799
open $0.4785 now $0.3752
-$0.1033 (-21.59%)
Past week
$0.4552 $0.5597
from $0.5399 now $0.3752
-$0.1647 (-30.51%)
Past month
$0.4552 $0.8100
from $0.7914 now $0.3752
-$0.4162 (-52.59%)
This year
$0.3706 $3.1500
from $2.8700 now $0.3752
-$2.4948 (-86.93%)

Price & Performance

-1.77 (-82.55%) / 6M

$0.2332$0.9195$1.61$2.29May 5Aug 6Nov 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.9% away from all-time highs of $533.0000
  • TPST is down 87% since the beginning of the year
  • TPST is down 96% over the past 12 months
  • TPST is down 53% over the past 1 month
  • 3% of all TPST investors are betting against TPST

TPST reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -96.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.34
Earnings momentum -6.2% Quarterly EPS growth
Quarterly change -6.2%

Valuation

P/E ratio N/A
Enterprise value $13.8M
Beta 2.40

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$779.0K
Debt$7.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.4M

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $460.28 -3.80%
MRNA Moderna, Inc. $241.46 -6.55%
RVMD Revolution Medicines, Inc. $177.65 -11.04%
ROIV Roivant Sciences Ltd. $36.62 -4.21%
BNTX BioNTech SE Sponsored ADR $85.86 -5.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.